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ABSTRACT The membrane-disruptive antimicrobial peptide PGLa is found to change its orientation in a dimyristoyl-
phosphatidylcholine bilayer when its concentration is increased to biologically active levels. The alignment of the a-helix was
determined by highly sensitive solid-state NMR measurements of 19F dipolar couplings on CF3-labeled side chains, and
supported by a nonperturbing 15N label. At a low peptide/lipid ratio of 1:200 the amphiphilic peptide resides on the membrane
surface in the so-called S-state, as expected. However, at high peptide concentration ($1:50 molar ratio) the helix axis changes
its tilt angle from ;90 to ;120, with the C-terminus pointing toward the bilayer interior. This tilted ‘‘T-state’’ represents a novel
feature of antimicrobial peptides, which is distinct from a membrane-inserted I-state. At intermediate concentration, PGLa is in
exchange between the S- and T-state in the timescale of the NMR experiment. In both states the peptide molecules undergo
fast rotation around the membrane normal in liquid crystalline bilayers; hence, large peptide aggregates do not form. Very likely
the obliquely tilted T-state represents an antiparallel dimer of PGLa that is formed in the membrane at increasing concentration.
INTRODUCTION
PGLa (GMASKAGAIAGKIAKVALKAL-NH2) is an antibi-
otic peptide found in frog skin (Hoffmann et al., 1983;
Richter et al., 1985; Soravia et al., 1988; Latal et al., 1997).
As a member of the magainin family it assumes an
amphiphilic a-helical structure upon membrane binding
(Bechinger et al., 1998). The cationic peptide has a high
afﬁnity for bacterial membranes and is able to permeabilize
them. A speciﬁc receptor is not involved in this antimicrobial
action (Wade et al., 1990); hence, it is unlikely that bacteria
develop resistance against such peptides. Several different
models of antimicrobial action have been proposed (McEl-
haney and Prenner, 1999; Shai, 1999; Matsuzaki, 1999;
Huang, 2000; Zasloff, 2002; Strandberg and Ulrich, 2004).
Initially, amphiphilic peptides are supposed to bind ﬂat to
the membrane surface in the so-called ‘‘S-state’’. Above
a threshold concentration the membrane may then get
disrupted nonspeciﬁcally by the high surface density, as in
the carpet mechanism. Alternatively, a realignment of the
peptide molecules into a membrane-inserted ‘‘I-state’’ has
been demonstrated, leading to the formation of oligomeric
pores. Here, it is appropriate to differentiate between the
‘‘barrel-stave’’ model in which the pore is exclusively made
up of peptide molecules, and the ‘‘toroidal wormhole’’
model in which anionic lipids contribute to the pore lining. A
better understanding of the structural basis for these different
functional mechanisms may help to improve the activity and
speciﬁcity of antimicrobial peptides.
We have recently developed a highly sensitive solid-state
19F-NMR strategy for characterizing the orientation and
dynamics of membrane-bound peptides, based on collecting
a number of orientational constraints (Salgado et al., 2001;
Afonin et al., 2003, 2004; Glaser and Ulrich, 2003; Glaser
et al., 2004; Ulrich, 2005; Ulrich et al., 2005). The most
appropriate label for obtaining these structural data is L-4-
triﬂuoromethyl-phenylglycine (CF3-Phg), when substituted
for a single nonpolar amino acid in the peptide sequence. The
anisotropic 19F-19F dipolar coupling within the CF3 group is
resolved by 19F-NMR measurements using macroscopically
aligned membrane samples (Glaser et al., 2004). The dipolar
splittings from several individual labels serve as experimen-
tal constraints to determine the orientation of the peptide
within the lipid bilayer. For PGLa reconstituted in DMPC
(dimyristoyl-phosphatidylcholine) at a peptide/lipid molar
ratio (P/L) of 1:200 we have previously demonstrated that
the helix is aligned ﬂat in the plane of the membrane. The tilt
angle of ;90 between the helix axis and the membrane
normal corresponds to the surface-bound S-state, as expected
from the amphiphilic character of the peptide. We have now
studied PGLa at higher concentration (P/L $ 1:50), since
antimicrobial peptides tend to become biologically active
only above such threshold value (Blazyk et al., 2001). Here,
we observed an unexpected realignment of the peptide,
whereby the helix axis assumes an oblique tilt angle. This
new orientation is clearly distinct from a transmembrane
alignment, and it does not correspond to an I-state, which
would have been expected for such peptides when a pore is
formed (Huang, 2000). Instead, it appears that PGLa is able
to self-assemble as a dimer on the bilayer surface at high
peptide concentration, which would explain how its tilted
orientation in the membrane is stabilized as a distinct state.
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MATERIALS AND METHODS
19F-NMR analysis
A series of CF3-Phg labeled PGLa analogs were synthesized, puriﬁed, and
characterized to be functionally fully intact, as previously reported (Afonin
et al., 2003; Glaser et al., 2004). A single label was introduced either at
position Ile-9, Ala-10, Ile-13, or Ala-14. Macroscopically oriented samples
with a mixture of 0.2–0.5 mg peptide plus lipid in different molar ratios were
prepared as previously described, and one-pulse 19F-NMR spectra were
acquired on a 500-MHz wide-bore Unity Inova spectrometer (Varian, Palo
Alto, CA) with a 19F/1H double-tuned ﬂat-coil probe (Doty Scientiﬁc,
Columbia, SC) that can be manually rotated and allows 1H decoupling with
10–15 kHz (Glaser et al., 2004).
15N-NMR analysis
15N-labeled PGLa was synthesized by standard Fmoc solid phase synthesis
with 15N-glycine at Gly-11. For the sample with P/L ¼ 1:200, ;1 mg of
peptide plus 70 mg DMPC were oriented on 25 glass plates, and 2.7 mg
PGLa plus 47 mg lipid were used for the P/L 1:50 sample. 15N-NMR
experiments were performed at 50.68 MHz on a Bruker Avance 500 MHz
NMR spectrometer with a ﬁxed ﬂat-coil triple-resonance probe (Bruker,
Karlsruhe, Germany). We used a ramped cross-polarization sequence with
a power of 40 kHz, 2.5 s relaxation delay time, 100 kHz spectral width, 2048
data points, and tppm20 proton decoupling. The contact time was 1 ms in
hydrated samples, and 2 ms for the lyophilized peptide. Between 30,000 and
200,000 scans were collected. Spectra were referenced to 15NH4NO3 by
setting the signal of solid 15NH4Cl to 18.0 ppm.We determined the principal
axis values of the 15N chemical shift anisotropy (CSA) tensor as s11 ¼ 14,
s22 ¼ 33, and s33 ¼ 197 ppm by ﬁtting the lineshape to the experimental
spectrum of the lyophilized peptide powder. We used an orientation of the
15N tensor of the labeled glycine with s33 tilted 17 from N-H toward the N-
C9 bond, and s11 normal to the plane of the peptide bond (Sternberg et al.,
2004).
RESULTS AND DISCUSSION
Concentration-dependent realignment of PGLa
in DMPC
The one-pulse 19F-NMR spectra of the four different labeled
PGLa analogs were measured at different peptide/lipid ratios
in DMPC membranes at 35C (Fig. 1). At low peptide
concentration, i.e., between 1:1000 and 1:200, the dipolar
analysis yielded a surface alignment as previously described
(Glaser et al., 2004). Upon increasing the P/L to 1:50 and
beyond, the chemical shift and dipolar couplings of the labels
changed (Table 1). In the following, we will analyze and
interpret the structural meaning of these spectral changes,
providing new insight into the peptide-lipid interactions of
antimicrobial peptides. A similar observation of a concentra-
tion-dependent change in NMR parameters had been
reported for a 4F-Phg labeled PGLa (Glaser and Ulrich,
2003) as well as a related model peptide K3 (Toke et al.,
2004). At that time, no structural interpretation had been
possible in these systems.
Using 31P-NMR, we conﬁrmed that the phospholipids
remain in a lamellar bilayer phase at all concentrations,
irrespective of the peptide orientation (Sachse, 2003). We
observed a slight smooth change of the anisotropic 31P
chemical shift of the lipids, roughly proportional to peptide
concentration. Such a qualitative reduction of lipid headgroup
order was also observed with many other molecules dissolved
in membranes (Zidovetzki et al., 1988). There was no
indication of phase separation between bound and free lipids,
nor between peptide-rich and peptide-depleted regions. The
uncharged lipid DMPC allowed a highly reproducible
preparation of samples with well-oriented bilayers. As the
oriented samples contain no excess bulk water, anionic lipids
are not necessary to attract the peptides to the membranes.
Conﬁrmation of realignment in DMPC/DMPG
(dimyristoyl-phosphatidylglycerol)
To determine the alignment of PGLa in the membrane from
the local orientational constraints of its four labels, the
peptide secondary structure has to be veriﬁed. Circular
dichroism was used to conﬁrm that the helix content of all
four analogs is comparable to that of the wild-type peptide in
the presence of small unilamellar vesicles at a P/L of 1:50
and 1:200 (see Supplementary Material). Unlike the solid-
state 19F-NMR experiments above, circular dichroism (CD)
measurements are performed on vesicles in dilute suspen-
sion. Hence, negatively charged lipids are required to attract
the cationic PGLa to the membrane. Under those conditions
we have previously shown by solution-state 19F-NMR that
the fraction of membrane-bound PGLa increases when neg-
atively charged dimyristoyl-phosphatidylglycerol (DMPG)
is mixed into the vesicles of DMPC (Afonin et al., 2003).
Once the overall negative charge of the lipids exceeded the
positive charge of PGLa (15 at neutral pH), virtually all
PGLa was associated to the membrane and the concentration
in bulk solution became immeasurably small.
FIGURE 1 Solid-state 19F-NMR spectra of PGLa-Ile13-CF3Phg at 35C
in oriented DMPC membranes with different P/L ratios. The membrane
normal is oriented parallel to the B0-ﬁeld. The dipolar coupling within the
CF3-group is read from the splitting of the triplet, and its sign is taken from
the chemical shift. The asymmetric shape of the triplet results from differ-
ential relaxation properties (Glaser et al., 2004).
TABLE 1 19F dipolar couplings (in kHz) of
CF3-Phg-labeled PGLa
Labeled position Ile-9 Ala-10 Ile-13 Ala-14
P/L ratio 1:200 0 0 5.6 5.4
P/L ratio 1:50 4.7 3.1 3.3 5.3
Realignment of PGLa in the Membrane 3393
Biophysical Journal 88(5) 3392–3397
To test the inﬂuence of negative lipid charge on peptide
orientation and to justify the CD-derived secondary structure
information, we acquired further solid-state 19F-NMR spec-
tra of a labeled PGLa analog in mixtures of DMPC and
DMPG. Measurements in oriented membranes were per-
formed at 1:200 and 1:50 molar peptide/lipid ratio (Fig. 2).
The linewidth on these spectra was higher than in samples
containing only DMPC. The reason for the line broadening is
not clear at this point, but differences in hydration properties
and 1H decoupling are likely. Nevertheless, for 3:1 and 1:1
DMPC/DMPG we found the same qualitative changes in the
spectra as in DMPC alone, which is clearly indicative of
a reorientation from the S-state at 1:200 to a new state at
1:50. Given that the conformation of PGLa remains a-helical
in all cases, the observed changes in the 19F-NMR spectra
must therefore be attributed to a concentration-induced re-
alignment of PGLa in the membrane.
Calculation of helix tilt angle
The orientation of PGLa in the bilayer can be calculated from
the signed dipolar splittings of the individual CF3-Phg labels
(see SupplementaryMaterial). The peptide orientation is fully
described by two angles: the tilt angle t between the helix axis
and the membrane normal, and the azimuthal rotation angle r
around the helix axis. With our deﬁnition of Ca of Lys-12 and
the helix axis as the base of themolecular coordinate system, t
 0 corresponds to an inserted orientation (I-state), and t 
90, r  80 . . . 120 corresponds to a surface orientation
according to the amphiphilic side-chain distribution of the
peptide. Additionally, the degree of motional averaging is
described by a molecular order parameter Smol. These three
parameters, t, r, and Smol are derived from the four dipolar
couplings by means of a least-squares ﬁt (Glaser et al., 2004;
Afonin et al., 2004). For PGLa at P/L¼ 1:200 theminimum in
the resulting r/tmap corresponds to the S-state, with t 89,
r  106, and Smol  0.6 (Fig. 3 A), as described before
(Glaser et al., 2004). At P/L¼ 1:50, on the other hand, we ﬁnd
that the allowed region in the r/tmap has moved to t 123,
r 85, with Smol 0.6 (Fig. 3B). Now the helix axis is tilted
at an oblique angle, with the C-terminus of PGLamore deeply
inserted into the lipid bilayer than the N-terminus. The
azimuthal angle has also changed to some extent, though
the amphiphilicity proﬁle of PGLa is still compatible with the
charged side chains reaching up toward the aqueous layer.We
shall name this novel tilted state the ‘‘T-state’’.
In a concentration-dependent series of experiments from
1:400 to 1:35, at low peptide concentration (1:400–1:150)
the splitting in Fig. 1 is 15.6 kHz, whereas at high
concentration (1:50, 1:35) the splitting is 3.3 kHz. There is
not a gradual change of the splitting, which indicates that
there is not a gradual change of peptide orientation. At
intermediate concentration the spectra are broadened to such
an extent that the two outer peaks of the triplet are not
detectable, i.e., the peptide changes between the S- and
T-states in the timescale of the NMR experiment. The same
concentration-dependent change between two distinct states
has also been observed for PGLa labeled with 4F-phenyl-
glycine, when an extensive concentration range was studied
from 1:3000 to 1:8. Here, the chemical shift underwent
a distinct change at a limiting threshold concentration of
around 1:100 (Glaser and Ulrich, 2003).
Peptide mobility in the membrane
The orientational analysis above yielded an order parameter
of Smol  0.6 for PGLa in both the S- and the T-states in
liquid crystalline DMPC. On a scale of 1.0 (no averaging) to
FIGURE 2 19F-NMR spectra of PGLa (as in Fig. 1) in oriented mem-
branes with different mixtures of DMPC and DMPG.
FIGURE 3 Orientation of the PGLa helix in a DMPC bilayer at a 1:200
(upper panels) and 1:50 (lower panels) molar peptide/lipid ratio. The
contour plots A–D show the sum of squared deviations between the exper-
imental data and calculated values as a function of the helix tilt angle t and
the azimuthal rotation r, with best-ﬁtting orientations in dark red. (A and B)
Summary of the 19F-NMR analysis based on four CF3-Phg labels, and (C
and D) a single 15N label. The corresponding 15N spectra are shown in E and
F, with the powder lineshape of the lyophilized peptide superimposed.
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0.0 (isotropic tumbling) this value accounts for both the
global orientational mobility of the peptide with respect to
the membrane normal and the local wobbling motion of the
label.
Rotational diffusion of PGLa around the membrane
normal is not visible in the spectra acquired with the
membrane normal aligned parallel to the static magnetic ﬁeld
direction, but it is revealed when the sample is positioned at
a 90 angle, i.e., with the membrane normal perpendicular to
the ﬁeld (Salgado et al., 2001; Ulrich, 2004; Glaser et al.,
2004). All spectra at P/L ratios of 1:200 and 1:50 were found
to scale around the isotropic chemical shift by a factor of1/
2 compared to the respective spectrum acquired at 0 angle,
and no powder pattern or signal broadening was observed
(Fig. 4). This indicates that all NMR interactions are
averaged around the sample axis on the timescale of the
experiment (10 kHz spectral width). Thus, the PGLa mole-
cules rotate freely around the membrane normal, in both
the S- and T-states.
We can furthermore exclude that PGLa rotates around its
helical axis, since this would lead to identical dipolar
splittings for all labeled positions. Especially the dipolar
couplings of the epimeric D-CF3-Phg labels (see Supple-
mentary Material) are incompatible with such motion, which
besides would be energetically very unfavorable in view of
the amphiphilic character of PGLa.
Veriﬁcation of the peptide tilt angle by 15N-NMR
To decide whether the observed spectral changes at high
peptide concentration are genuinely due to an oblique tilt of
PGLa, we studied a peptide labeled with 15N at Gly-11. 15N-
NMR experiments have a much lower sensitivity compared
to 19F-NMR experiments (Afonin et al., 2003), but we can be
sure that this label does not perturb the local peptide
conformation nor its interactions with other molecules. At
low peptide concentration (P/L ¼ 1:200) the 15N signal of an
oriented sample is at 40 ppm, and at high concentration
(1:50) it moves to 68 ppm (Fig. 3, E and F). To ﬁnd out
which alignments of the peptide helix are compatible with
these data, the principal axis values of the 15N CSA tensor
need to be known. As Gly differs slightly from other amino
acids (Sternberg et al., 2004), the values were determined
from the lyophilized peptide powder, which is shown super-
imposed over the oriented spectra.
Orientational analysis of the 15N data in terms of t yielded
a tilt angle of 90 for a P/L of 1:200, conﬁrming the S-state,
as expected (Fig. 3 C). At a high peptide concentration of
1:50, we determined a helix tilt of about t  65 or 115,
which is also in full agreement with the 19F analysis (Fig. 3
D). This orientational analysis was performed with Smol ¼
0.7. For the 15N label in the backbone, a slightly higher order
parameter than 0.6 was chosen to compensate for any extra
wobble of the CF3-Phg side chain and any motion in the
lyophilized peptide. The signal lies close to (but not at) the
isotropic position of 15N, but free tumbling or micellarization
of the peptide can be excluded in view of the 19F- and 31P-
NMR data on equivalent samples. For any reasonable choice
of 0.5 , Smol , 1 only an oblique helix tilt can explain the
15N data at P/L¼ 1:50. The evaluation of an oblique helix tilt
angle thus unequivocally conﬁrms the self-consistent picture
derived above by 19F-NMR.
We note that the 15N-NMR signal at 40 ppm of the 1:50
sample is signiﬁcantly broader than the signal of the 1:200
sample at 68 ppm. This is an inevitable consequence of the
differential effect of the mosaic spread on the 15N chemical
shift in the different CSA tensor orientations. Namely, the
same mosaic spread produces an apparent linewidth that is
;3 times smaller near the high-ﬁeld and low-ﬁeld edge of
the CSA range (S-state) than in the middle of the CSA range
(T-state).
Further evidence for a realignment of PGLa from an
S-state to a T-state stems from analyzing the epimeric
byproducts of our peptide synthesis, namely those PGLa
analogs carrying a D-CF3-Phg label (see Supplementary
Material). The bulky and stiff D-amino acid is expected to
cause slight changes in the structure and in the hydrophobic
surface of the peptide; therefore, the dipolar couplings only
provide qualitative information about the orientation of the
peptide (Glaser et al., 2004). Nevertheless, these measure-
ments also conﬁrmed the obliquely tilted orientation of
PGLa at high concentration in the membrane, and they
clearly excluded the possibility of a transmembrane orien-
tation of the PGLa helix.
Interpretation in terms of peptide dimerization
Notably, the concentration-dependent series of experiments
never showed a gradual shift of the signals (e.g., Fig. 1) (as
FIGURE 4 19F-NMR spectra of PGLa (as in Fig. 1) at a P/L of 1:50 in
oriented DMPCmembranes acquired with two different sample orientations.
Upper spectrum with the membrane normal aligned perpendicular to the
magnetic ﬁeld (90 tilt), and lower spectrum with the membrane normal
parallel to the magnetic ﬁeld (0 tilt). In addition, the idealized triplet
structure of the spectrum along with the isotropic chemical shift of CF3-Phg
(dotted line) are indicated.
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also observed in Glaser and Ulrich, 2003). At peptide/lipid
ratios around 1:100, the NMR signal deteriorates because of
exchange between the two populations in the intermediate
timescale. This is taken as evidence for the presence of two
distinct populations of peptides in different orientational
states, separated by an energy barrier. A tilted state with
t ¼ 120would not seem to be a particularly favorable align-
ment for a monomer of PGL, which is already perfectly sta-
ble in a ﬂat alignment (S-state). Hence, the change from the
S- to the T-state must involve more than just a change in
orientation with respect to the membrane. Signiﬁcant
conformational changes were excluded by CD experiments,
and are very unlikely since our NMR data ﬁts well with
a helical conformation in both states. The formation of large
peptide aggregates can also be excluded in view of the
observed fast rotation around the membrane normal and the
same Smol at low concentration. Therefore, although we have
no direct experimental evidence, the most probable expla-
nation for the occurrence of the T-state is the formation of
peptide dimers upon increasing the PGLa concentration in
the membrane. Indeed, PGLa is known to form dimers in
a lipid monolayer at the air-water interface (Konovalov et al.,
2002). Dimerization in the membrane has even been
described for related antimicrobial peptides: REDOR
distance measurements on the model peptide K3 showed
parallel dimers (Toke et al., 2004), transferred NOE of
a magainin analog indicated antiparallel dimers (Wakamatsu
et al., 2002), and PGLa was found to associate with magainin
as an antiparallel heterodimer (Hara et al., 2001). The tilt
angle of such peptide dimers in the membrane has not yet
been determined, as these experiments provided distance
constraints but no orientational information. In our case of
PGLa, the homodimers in DMPC must be rotationally
symmetric with respect to the membrane normal, since we
observe only a single set of NMR signals. The tilt of the
monomer is then a consequence of the dimer orientation
according to its overall amphiphilic shape. Self-assembly of
PGLa into antiparallel dimers may thus account for the
observation of the distinctly tilted T-state, as schematically
illustrated in Fig. 5.
Assessment of error margins
An experimental inaccuracy of 60.5 kHz in the dipolar
splitting translates into an intrinsic error in t and r of,610
(Glaser et al., 2004). Nevertheless, this margin includes the
ambiguity of choosing one or another helical conformation
for the data analysis, as demonstrated by our systematic
analysis of different conformational models (see Supplemen-
tary Material). Since the L-CF3-Phg labels used to replace Ile
or Ala may induce slight distortions in the peptide backbone,
the error margins should be considered more generously, say
at 620. Especially in the T-state, which appears to involve
speciﬁc peptide-peptide interactions, the stiff CF3-Phg labels
might be more problematic than in the monomeric S-state.
The information from a single nonperturbing 15N-label is not
very accurate either (about 620 in t, and r is generally not
accessible by 15NCSAanalysis of single labels). Nonetheless,
the distinct changes in the 19F dipolar couplings and in the 15N
chemical shift unequivocally show that PGLa undergoes
a concentration-dependent realignment.
With a small number of orientational constraints we can
only test whether a certain helix conformation and orien-
tation is compatible with the NMR data. In fact, the four
constraints from the L-CF3-Phg labels alone would also be
compatible with a distorted helix that is slightly tilted away
from a transmembrane orientation (see Supplementary
Material). However, the independent additional constraints
(13 15N-Gly, 43 D-CF3-Phg) supporting the oblique tilt of
the central helical segment of PGLa make any alternative
interpretation of the data very unlikely.
CONCLUSIONS
The tilted T-state of PGLa exhibits quite unexpected
properties that do not ﬁt well into the currently discussed
structural models of antimicrobial action (Shai, 1999;
Matsuzaki, 1999; Huang, 2000; Zasloff, 2002; Strandberg
and Ulrich, 2004). It is clearly not compatible with a barrel-
stave pore, and the rotational diffusion of the peptide
around the membrane normal does not support the carpet
model either. The oblique tilt with an order parameter
nearly identical to that of the S-state is also not compatible
with a toroidal wormhole. Although the high peptide
concentration of the T-state may appear to correlate with
the threshold for pore formation (Wieprecht et al., 2000),
there is no evidence from our experiments that this state
should be directly responsible for the destruction of
the membrane barrier. Dimerization of PGLa at the
membrane surface is a plausible hypothesis to explain our
data in light of observations from similar amphiphilic
helical membrane peptides from the same family. The
T-state may thus be an intermediate in the formation of
pores on the way from the monomeric S-state toward
a cooperative I-state.
FIGURE 5 Illustration of the observed realignment of PGLa in a DMPC
membrane. At low peptide concentration, the amphiphilic helix lies ﬂat on
the surface in the S-state. With increasing concentration, it assumes a tilted
T-state, which appears to involve the formation of antiparallel peptide
dimers.
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SUPPLEMENTARY MATERIAL
An online supplement to this article can be found by visiting
BJ Online at http://www.biophysj.org.
CD experiments, 19F-NMR experiments with D-CF3-Phg labeled peptides,
and effect of structural variation on peptide orientation are available as
supporting material in PDF format; the orientational calculation of t and r
is available as MATHEMATICA notebook.
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